外周 T 细胞淋巴瘤：当前方法的回顾及未来的希望。
Peripheral T-cell lymphomas: a review of current approaches and hopes for the future.
机构信息
Medical Oncology, Fox Chase Cancer Center , Philadelphia, PA , USA.
出版信息
Front Oncol. 2013 May 28;3:138. doi: 10.3389/fonc.2013.00138. eCollection 2013.
Abstract
Peripheral T-cell lymphomas (PTCL) are a diverse group of lymphoproliferative disorders, which share a common denominator of overall poor prognosis, with few exceptions. In this article, the authors review current standard of care approaches for the treatment of PTCLs, the role of stem-cell/bone marrow transplantation, and current developments in novel targeted therapies.
摘要
外周 T 细胞淋巴瘤（PTCL）是一组异质性的淋巴增殖性疾病，除了少数例外，它们的总体预后都很差。本文作者回顾了目前 PTCL 治疗的标准护理方法、干细胞/骨髓移植的作用，以及新型靶向治疗的最新进展。
相似文献
1
Peripheral T-cell lymphomas: a review of current approaches and hopes for the future.
Front Oncol. 2013 May 28;3:138. doi: 10.3389/fonc.2013.00138. eCollection 2013.
2
Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Peripheral T-cell lymphomas.
Crit Rev Oncol Hematol. 2016 Mar;99:214-27. doi: 10.1016/j.critrevonc.2015.12.016. Epub 2016 Jan 3.
3
Novel therapies for peripheral T-cell lymphomas.
Ther Adv Hematol. 2013 Jun;4(3):173-87. doi: 10.1177/2040620713481980.
4
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma.
Cancer Treat Rev. 2014 Oct;40(9):1080-8. doi: 10.1016/j.ctrv.2014.08.001. Epub 2014 Aug 24.
5
Treatment of peripheral T-cell lymphoma: are we data driven or driving the data?
Curr Treat Options Oncol. 2013 Jun;14(2):212-23. doi: 10.1007/s11864-013-0232-x.
6
Chemotherapeutic advancements in peripheral T-cell lymphoma.
Semin Hematol. 2014 Jan;51(1):17-24. doi: 10.1053/j.seminhematol.2013.11.006. Epub 2013 Nov 14.
7
Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma.
Curr Hematol Malig Rep. 2020 Aug;15(4):316-332. doi: 10.1007/s11899-020-00590-5.
8
A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma.
Blood. 2018 Jan 25;131(4):397-407. doi: 10.1182/blood-2017-09-806737. Epub 2017 Nov 15.
9
New drug therapies in peripheral T-cell lymphoma.
Expert Rev Anticancer Ther. 2011 Mar;11(3):457-72. doi: 10.1586/era.11.4.
10
Romidepsin for the Treatment of Peripheral T-Cell Lymphoma.
Oncologist. 2015 Sep;20(9):1084-91. doi: 10.1634/theoncologist.2015-0043. Epub 2015 Jun 22.
引用本文的文献
1
Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers.
Cancers (Basel). 2020 Jan 18;12(1):240. doi: 10.3390/cancers12010240.
2
F-FDG PET/CT imaging findings in anaplastic large cell lymphoma, a rare subtype of lymphoma.
Cancer Imaging. 2020 Jan 10;20(1):4. doi: 10.1186/s40644-019-0278-5.
3
Refractory Septic Shock due to Underlying Immunocompromised Disease: A Case of Fatal Peripheral T-Cell Lymphoma Not Otherwise Specified in a Young Hispanic Woman.
Case Rep Oncol. 2018 Jun 22;11(2):404-411. doi: 10.1159/000488312. eCollection 2018 May-Aug.
4
STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral T-cell lymphoma.
Oncotarget. 2018 Mar 30;9(24):16792-16806. doi: 10.18632/oncotarget.24698.
5
Early diagnosis of an isolated primary peripheral T-cell lymphoma masquerading as massive gingival enlargement in a pediatric patient.
J Oral Maxillofac Pathol. 2017 Sep-Dec;21(3):421-424. doi: 10.4103/jomfp.JOMFP_73_15.
6
Belinostat for Relapsed or Refractory Peripheral T-Cell Lymphoma.
J Adv Pract Oncol. 2016 Mar;7(2):209-218. doi: 10.6004/jadpro.2016.7.2.6. Epub 2016 Mar 1.
7
Concurrent Mutations in ATM and Genes Associated with Common γ Chain Signaling in Peripheral T Cell Lymphoma.
PLoS One. 2015 Nov 4;10(11):e0141906. doi: 10.1371/journal.pone.0141906. eCollection 2015.
8
Preclinical targeting of human T-cell malignancies using CD4-specific chimeric antigen receptor (CAR)-engineered T cells.
Leukemia. 2016 Mar;30(3):701-7. doi: 10.1038/leu.2015.311. Epub 2015 Nov 3.
9
Targets, Toxins, and T Cells--a Review of New Monoclonal Antibodies in the Treatment of Peripheral T Cell Lymphomas.
Curr Hematol Malig Rep. 2015 Dec;10(4):438-47. doi: 10.1007/s11899-015-0290-1.
10
Persistent complete remission of acute leukemic-phase CCR4-positive gamma-delta peripheral T-cell lymphoma by autologous stem cell transplantation with mogamulizumab.
Int J Hematol. 2015 Oct;102(4):498-505. doi: 10.1007/s12185-015-1805-1. Epub 2015 May 15.
本文引用的文献
1
Differential expression of aurora-A kinase in T-cell lymphomas.
Mod Pathol. 2013 May;26(5):640-7. doi: 10.1038/modpathol.2012.211. Epub 2013 Feb 15.
2
Peripheral T-cell lymphomas: analysis of histology, staging and response to treatment of 208 cases at a single institution.
Leuk Lymphoma. 2013 Nov;54(11):2392-8. doi: 10.3109/10428194.2013.776680. Epub 2013 Mar 27.
3
Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma.
Biol Blood Marrow Transplant. 2013 Apr;19(4):602-6. doi: 10.1016/j.bbmt.2013.01.006. Epub 2013 Jan 29.
4
A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT study.
Leuk Lymphoma. 2013 Jul;54(7):1373-9. doi: 10.3109/10428194.2012.742521. Epub 2013 Jan 29.
5
Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endo-reduplication and induces apoptosis in T-NHL cell lines supporting its importance in PTCL treatment.
Leuk Res. 2013 Apr;37(4):434-9. doi: 10.1016/j.leukres.2012.10.017. Epub 2012 Nov 12.
6
Results from a prospective, open-label, phase II trial of bendamustine in refractory or relapsed T-cell lymphomas: the BENTLY trial.
J Clin Oncol. 2013 Jan 1;31(1):104-10. doi: 10.1200/JCO.2012.43.7285. Epub 2012 Oct 29.
7
Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma.
Haematologica. 2013 Mar;98(3):357-63. doi: 10.3324/haematol.2012.069757. Epub 2012 Oct 12.
8
Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.
J Clin Oncol. 2012 Sep 1;30(25):3093-9. doi: 10.1200/JCO.2011.40.2719. Epub 2012 Jul 30.
9
Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 trial.
Eur J Cancer. 2012 Nov;48(17):3223-31. doi: 10.1016/j.ejca.2012.06.003. Epub 2012 Jul 4.
10
Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study.
J Clin Oncol. 2012 Jun 20;30(18):2190-6. doi: 10.1200/JCO.2011.38.0402. Epub 2012 May 21.
Zotero 插件